14-87945682-A-G
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000153.4(GALC):c.1541T>C(p.Phe514Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,216 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_000153.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GALC | NM_000153.4 | c.1541T>C | p.Phe514Ser | missense_variant | Exon 14 of 17 | ENST00000261304.7 | NP_000144.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 152042Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248836Hom.: 0 AF XY: 0.0000222 AC XY: 3AN XY: 134994
GnomAD4 exome AF: 0.00000685 AC: 10AN: 1460174Hom.: 0 Cov.: 31 AF XY: 0.00000964 AC XY: 7AN XY: 726464
GnomAD4 genome AF: 0.0000132 AC: 2AN: 152042Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74264
ClinVar
Submissions by phenotype
Galactosylceramide beta-galactosidase deficiency Pathogenic:4
- -
Variant summary: GALC c.1541T>C (p.Phe514Ser) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 1.2e-05 in 248836 control chromosomes. c.1541T>C has been reported in the literature in individuals affected with Krabbe Disease along with a second pathogenic allele (Wegner_1997, Lissens_2007, Fiumara_2011, Puckett_2012). Transfection studies showed the variant to result in mock levels of enzyme activity (Saavedra-Martiz_2016). Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
This sequence change replaces phenylalanine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 514 of the GALC protein (p.Phe514Ser). This variant is present in population databases (rs375867319, gnomAD 0.003%). This missense change has been observed in individual(s) with Krabbe disease (PMID: 9338580; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as p.Phe498Ser. ClinVar contains an entry for this variant (Variation ID: 289955). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GALC protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects GALC function (PMID: 27638593). For these reasons, this variant has been classified as Pathogenic. -
- -
not provided Pathogenic:3
- -
- -
PM2, PM3, PP3, PP4, PP5 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at